Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Option Care Health, Inc. (OPCH) SEC filings page brings together the company’s official regulatory disclosures, as filed with the U.S. Securities and Exchange Commission. These documents provide detailed insight into how the nation’s largest independent provider of home and alternate site infusion services reports its financial condition, capital structure, governance changes and material agreements.
Investors can use this page to access current and historical 10-K and 10-Q reports, which contain audited and interim financial statements, segment information, risk factor discussions and management’s analysis of the business. For Option Care Health, these filings complement its earnings press releases that discuss net revenue, net income, earnings per share and non-GAAP measures such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS, and they provide the underlying GAAP detail and reconciliations referenced in those releases.
The page also tracks Form 8-K filings, which Option Care Health uses to report material events. Recent examples include 8-Ks furnishing quarterly earnings press releases under Item 2.02, an 8-K describing a Fourth Amendment to the company’s Amended and Restated First Lien Credit Agreement under Item 1.01 and Item 2.03, and an 8-K outlining a Chief Financial Officer transition and related compensatory arrangements under Item 5.02. These filings explain changes to term loans and revolving credit facilities, leadership appointments and transitions, and other significant corporate actions.
Users interested in executive and director information can review proxy materials and governance-related filings, which describe board composition, executive compensation structures and incentive plans referenced in 8-K disclosures. For those monitoring potential insider activity, Form 4 and related ownership reports, when filed, show transactions by directors, officers and significant shareholders in OPCH stock.
To make this information more accessible, this page pairs real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight key points from lengthy filings. Instead of reading an entire credit agreement amendment or multi-hundred-page annual report, users can quickly see what changed in Option Care Health’s debt terms, how non-GAAP metrics reconcile to GAAP results, or what new risks and governance details have been disclosed, and then drill into the full documents as needed.
Option Care Health, Inc. director Harry M. Jansen Kraemer Jr. reported an open-market purchase of 36,610 shares of Common Stock on May 4, 2026. The shares were bought at a weighted average price of $21.4087 per share, with individual trade prices ranging from $21.35 to $21.475. Following this purchase, he directly owns 450,000 shares of Option Care Health, Inc.
Option Care Health, Inc. announced that Christopher L. Grashoff will depart from his role as Chief Growth Officer, effective May 8, 2026. The company states that Mr. Grashoff will receive separation benefits under its Amended and Restated Executive Severance Plan, subject to a general release of claims in favor of the company and his continued compliance with existing restrictive covenants.
Option Care Health, Inc. Chief Financial Officer Meenal Sethna bought 16,225 shares of common stock in an open-market purchase on May 4, 2026 at a weighted average price of $20.1587 per share.
The filing notes these shares were acquired through multiple trades at prices ranging from $19.94 to $20.38 per share. Following the transaction, Sethna directly owns 98,337 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Executive Officer John Charles Rademacher reported an open-market purchase of 12,500 shares of common stock on May 4, 2026 at a weighted average price of $21.1765 per share. Following this transaction, he directly owns 695,152 common shares.
The shares were bought in multiple trades that day at prices ranging from $21.14 to $21.18 per share, indicating a modest incremental increase to his existing equity stake in the company.
Option Care Health reported steady Q1 2026 results, with net revenue of $1,350.7M, up slightly from $1,333.0M a year earlier. Net income was $45.3M versus $46.7M and diluted EPS rose to $0.29 from $0.28 as the share count declined.
Gross profit edged down to $262.0M and margin slipped to 19.4%, as strength in acute therapies was offset by pressure in chronic inflammatory disease treatments. Management now expects chronic inflammatory disease dynamics to reduce 2026 gross profit by about $55M.
The company ended the quarter with $177.3M in cash and expanded its revolving credit facility to $850.0M, leaving $846.0M available. It also repurchased 528,981 shares for $17.5M, with $675.0M remaining under its $1.0B authorization.
Vanguard Capital Management reports beneficial ownership of 8,228,614 shares (5.25%) of Option Care Health Inc common stock as of 03/31/2026. The filing states Vanguard has sole dispositive power over 8,228,614 shares and sole voting power for 1,212,291 shares. The disclosure notes these holdings include securities held for Vanguard funds and certain managed accounts and lists affiliated Vanguard entities that exercise voting or dispositive power.
Option Care Health reported mixed first quarter 2026 results, with net revenue of $1,350.7 million, up 1.3% year over year. GAAP net income was $45.3 million, down 3.0%, while GAAP diluted EPS rose to $0.29 and Adjusted diluted EPS held flat at $0.40.
Adjusted EBITDA was $104.8 million, down 6.3%, and operating activities used $12.1 million of cash. The company repurchased $17.5 million of stock and expanded its revolving credit facility from $400 million to $850 million, adding financial flexibility.
For full year 2026, Option Care Health now guides to net revenue of $5.675–$5.775 billion, Adjusted EBITDA of $480–$505 million, Adjusted diluted EPS of $1.82–$1.92, and at least $320 million of cash provided by operating activities, reflecting modest growth expectations.
Option Care Health Inc ownership disclosure: Vanguard Portfolio Management reported beneficial ownership of 8,201,422 shares of Common Stock, representing 5.24% of the class as of 03/31/2026. The filing notes these shares are held on behalf of Vanguard funds and managed accounts.
Option Care Health Chief Medical Officer Femi Adewunmi reported a tax-withholding disposition of 1,396 shares of Common Stock on April 22, 2026 at $28.38 per share. After this automatic withholding to cover tax obligations, Adewunmi directly holds 25,314 shares of Option Care Health Common Stock.